(Q51071921)

English

Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis.

scientific article published in October 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24965881

Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24965881

object named as

Fiona E McCann

1

0 references

author name string

Dany P Perocheau

2

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24965881

Gerhard Ruspi

3

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24965881

Katrina Blazek

4

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24965881

Marie L Davies

5

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24965881

Marc Feldmann

6

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24965881

Jonathan L E Dean

7

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24965881

A Allart Stoop

8

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24965881

Richard O Williams

9

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24965881

publication date

1 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24965881

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24965881

66

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24965881

10

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24965881

2728-2738

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24965881

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

TNF downmodulates the function of human CD4+CD25hi T-regulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation.

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells.

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells.

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood.

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

TNF-R1 signaling: a beautiful pathway

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Targeting TNF receptors in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Lack of TNFR p55 results in heightened expression of IFN-γ and IL-17 during the development of reactive arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression.

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway.

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

T helper 17 cell heterogeneity and pathogenicity in autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Th17 cytokines and arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment.

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor.

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Association of the major histocompatibility complex with response to infliximab therapy in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Anti-TNF-α therapy improves Treg and suppresses Teff in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38755

21 January 2018

Identifiers

10.1002/ART.38755

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24965881

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/24965881

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51071921&oldid=951359703"